{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:08:47Z","timestamp":1760299727869},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.oooo.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T20:05:43Z","timestamp":1509739543000},"page":"164-171","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A preliminary immunohistochemical study of signal transducer and activator of transcription (STAT) proteins in primary oral malignant melanoma"],"prefix":"10.1016","volume":"125","author":[{"given":"Nikolaos G.","family":"Nikitakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Gkouveris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erofili","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Argyrios","family":"Daskalopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Sklavounou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2017.10.007_bib0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.oraloncology.2008.04.015","article-title":"Primary oral melanoma: population-based incidence","volume":"45","author":"Sortino-Rachou","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.oraloncology.2011.12.014","article-title":"Primary malignant melanoma, of head and neck: a comprehensive review of literature","volume":"48","author":"Vikey","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0020","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.joms.2006.10.044","article-title":"Oral malignant melanoma: the Amsterdam experience","volume":"65","author":"Meleti","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.007_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.oooo.2016.01.005","article-title":"Primary mucosal melanoma of the oral cavity: current therapy and future directions","volume":"122","author":"Chatzistefanou","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0030","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0030-4220(53)90242-4","article-title":"Primary malignant melanoma of the oral mucosa","volume":"6","author":"Greene","year":"1953","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0035","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/DAD.0000000000000035","article-title":"Head and neck mucosal melanoma: a review","volume":"36","author":"Louren\u00e7o","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0040","first-page":"6","article-title":"Oral amelanotic melanoma","volume":"10","author":"Adisa","year":"2012","journal-title":"Ann Ib Postgrad Med"},{"key":"10.1016\/j.oooo.2017.10.007_bib0045","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0714.2008.00660.x","article-title":"Oral malignant melanoma: a review of the literature","volume":"37","author":"Femiano","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.oooo.2017.10.007_bib0050","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1079-2104(03)00320-2","article-title":"Intraoral melanoma: long-term follow-up and implication for dental clinicians. A case report and literature review","volume":"96","author":"Gu","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2017.10.007_bib0055","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.joms.2016.03.008","article-title":"Survival outcomes of mucosal melanoma in the head and neck: case series and review of current treatment guidelines","volume":"74","author":"Breik","year":"2016","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.007_bib0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3315\/jdcr.2014.1175","article-title":"Melanoma of the oral cavity: pathogenesis, dermoscopy, clinical features, staging and management","volume":"8","author":"Warszawik-Hendzel","year":"2014","journal-title":"J Dermatol Case Rep"},{"key":"10.1016\/j.oooo.2017.10.007_bib0065","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0278-2391(03)00670-0","article-title":"Primary malignant melanoma of the oral mucosa","volume":"61","author":"Rapidis","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.007_bib0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1368-8375(99)00085-8","article-title":"Oral mucosal melanoma: epidemiology and pathobiology","volume":"36","author":"Hicks","year":"2000","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12105-017-0789-y","article-title":"Update from the 4th edition of the World Health Organization Classification of Head and Neck Tumours: mucosal melanomas","volume":"11","author":"Williams","year":"2017","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pathol.2016.09.065","article-title":"BRAF, NRAS, KIT, TERT, GNAQ\/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases","volume":"49","author":"\u00d6zt\u00fcrk-Sari","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.oooo.2017.10.007_bib0085","first-page":"783","article-title":"NRAS and BRAF mutation frequency in primary oral mucosal melanoma","volume":"26","author":"Buery","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.oooo.2017.10.007_bib0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/jop.12358","article-title":"Mutation scanning of BRAF, NRAS, KIT, and GNAQ\/GNA11 in oral mucosal melanoma: a study of 57 cases","volume":"45","author":"Lyu","year":"2016","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.oooo.2017.10.007_bib0095","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hed.23079","article-title":"Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases","volume":"35","author":"Turri-Zanoni","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.oooo.2017.10.007_bib0100","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1038\/onc.2016.486","article-title":"Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK\/PI3 K inhibition or MEK\/CDK4\/6 inhibition","volume":"36","author":"Kim","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.oooo.2017.10.007_bib0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-007-0524-2","article-title":"C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma","volume":"452","author":"Rivera","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.oooo.2017.10.007_bib0110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0749.2004.00164.x","article-title":"The transcription network regulating melanocyte development and melanoma","volume":"17","author":"Vance","year":"2004","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.oooo.2017.10.007_bib0115","doi-asserted-by":"crossref","first-page":"e24064","DOI":"10.1371\/journal.pone.0024064","article-title":"C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferation","volume":"6","author":"Phung","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.oooo.2017.10.007_bib0120","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/00000478-200106000-00010","article-title":"Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa","volume":"25","author":"Prasad","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0125","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.humpath.2007.07.003","article-title":"Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas","volume":"39","author":"Kondratiev","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/DAD.0b013e318276cab3","article-title":"Adhesion molecules in primary oral mucosal melanoma: study of claudins, integrins and immunoglobulins in a series of 35 cases","volume":"35","author":"Bologna","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0135","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1600-0463.2007.apm_855.xml.x","article-title":"The genome and epigenome of malignant melanoma","volume":"115","author":"Dahl","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.oooo.2017.10.007_bib0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/DAD.0b013e31825fa1f6","article-title":"The CDKN2 A and MAP kinase pathways: molecular roads to primary oral mucosal melanoma","volume":"35","author":"Hsieh","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0145","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1368-8375(00)00107-X","article-title":"Expression of Rb, pRb2\/p130, p53, and p16 proteins in malignant melanoma of oral mucosa","volume":"37","author":"Tanaka","year":"2001","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0150","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4236\/jct.2015.68078","article-title":"STAT3 signaling in cancer","volume":"6","author":"Gkouveris","year":"2015","journal-title":"J Cancer Ther"},{"key":"10.1016\/j.oooo.2017.10.007_bib0155","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.oraloncology.2015.03.004","article-title":"Review of STAT3 (signal transducers and activators of transcription) in head and neck cancer","volume":"51","author":"Mali","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0160","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2174\/1568009043332736","article-title":"Targeting the STAT pathway in head and neck cancer: recent advances and future prospects","volume":"4","author":"Nikitakis","year":"2004","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.oooo.2017.10.007_bib0165","first-page":"104","article-title":"The role of Stat5 transcription factors as tumor suppressors or oncogenes","volume":"1815","author":"Ferbeyre","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.oooo.2017.10.007_bib0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ccr.2004.12.010","article-title":"Stat5 tetramer formation is associated with leukemogenesis","volume":"7","author":"Moriggl","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.oooo.2017.10.007_bib0175","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4161\/cbt.7.7.6535","article-title":"Transcriptional control of the melanoma malignant phenotype","volume":"7","author":"Melnikova","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.oooo.2017.10.007_bib0180","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/CMR.0b013e32830ce7d7","article-title":"STAT5 contributes to antiapoptosis in melanoma","volume":"18","author":"Hassel","year":"2008","journal-title":"Melanoma Res"},{"key":"10.1016\/j.oooo.2017.10.007_bib0185","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1349-7006.2004.tb02194.x","article-title":"Interferon-beta gene therapy for cancer: basic research to clinical application","volume":"95","author":"Yoshida","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.oooo.2017.10.007_bib0190","doi-asserted-by":"crossref","first-page":"e24705","DOI":"10.1371\/journal.pone.0024705","article-title":"Timing is critical for an effective anti-metastatic immunotherapy: the decisive role of IFN\u03b3\/STAT1-mediated activation of autophagy","volume":"6","author":"Yan","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.oooo.2017.10.007_bib0195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.joms.2013.06.198","article-title":"Phosphorylated signal transducer and activator of transcription-1 immunohistochemical expression is associated with improved survival in patients with oral squamous cell carcinoma","volume":"72","author":"Pappa","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.007_bib0200","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/BJ20120941","article-title":"Selective STAT3-\u03b1 or -\u03b2 expression reveals splice form-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes","volume":"447","author":"Ng","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.oooo.2017.10.007_bib0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/jir.2012.0154","article-title":"STAT activation in malignancies: roles in tumor progression and in the generation of antineoplastic effects of IFNs","volume":"33","author":"Wang","year":"2013","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.oooo.2017.10.007_bib0210","first-page":"1065","article-title":"ERK1\/2, JNK and STAT3 activation and correlation with tumor differentiation in oral SCC","volume":"32","author":"Gkouveris","year":"2017","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.oraloncology.2015.11.022","article-title":"The STAT3 pathway as a therapeutic target in head and neck cancer: barriers and innovations","volume":"56","author":"Geiger","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0225","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1038\/sj.onc.1205859","article-title":"Roles of activated Src and Stat3 signaling in melanoma tumor cell growth","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.oooo.2017.10.007_bib0230","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/107327480801500302","article-title":"Activated STAT-3 in melanoma","volume":"15","author":"Messina","year":"2008","journal-title":"Cancer Control"},{"key":"10.1016\/j.oooo.2017.10.007_bib0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10555-005-1580-1","article-title":"Targeting STAT3 affects melanoma on multiple fronts","volume":"24","author":"Kortylewski","year":"2005","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.oooo.2017.10.007_bib0240","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/onc.2013.45","article-title":"Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor","volume":"33","author":"Becker","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.oooo.2017.10.007_bib0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1751-1097.2007.00254.x","article-title":"Understanding signaling cascades in melanoma","volume":"84","author":"Lopez-Bergani","year":"2008","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0245","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1158\/1078-0432.CCR-06-1387","article-title":"Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNa2 b","volume":"13","author":"Wang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oooo.2017.10.007_bib0250","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.3800750","article-title":"Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma","volume":"20","author":"Zhuang","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0255","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/cncr.26511","article-title":"Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I\/II melanoma","volume":"118","author":"Jensen","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.oooo.2017.10.007_bib0260","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/CMR.0b013e32834acc37","article-title":"Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma","volume":"21","author":"Wu","year":"2011","journal-title":"Melanoma Res"},{"key":"10.1016\/j.oooo.2017.10.007_bib0265","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/exd.12802","article-title":"Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells","volume":"24","author":"Tagami-Nagata","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0270","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4238\/2015.February.6.9","article-title":"Effect of curcumin on the proliferation, apoptosis, migration, and invasion of human melanoma A375 cells","volume":"14","author":"Zhang","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.oooo.2017.10.007_bib0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1476-4598-9-165","article-title":"The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity","volume":"9","author":"Bill","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.oooo.2017.10.007_bib0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030532","article-title":"Vanillin suppresses cell motility by inhibiting STAT3-mediated HIF-1 \u03b1 mRNA expression in malignant melanoma cells","volume":"18","author":"Park","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oooo.2017.10.007_bib0285","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/excr.1999.4470","article-title":"Specific activation of a STAT family member in Xiphophorus melanoma cells","volume":"249","author":"Baudler","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.oooo.2017.10.007_bib0290","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1038\/sj.jid.5700385","article-title":"STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases","volume":"126","author":"Mirmohammadsadegh","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0295","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.cub.2005.08.036","article-title":"STAT5 contributes to interferon resistance of melanoma cells","volume":"15","author":"Wellbrock","year":"2005","journal-title":"Curr Biol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0300","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1471-2407-13-251","article-title":"Variant G6 PD levels promote tumor cell proliferation or apoptosis via the STAT3\/5 pathway in the human melanoma xenograft mouse model","volume":"13","author":"Hu","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.oooo.2017.10.007_bib0305","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.0022-202X.2004.22237.x","article-title":"Interferon-gamma-mediated growth regulation of melanoma cells: involvement of STAT1-dependent and STAT1-independent signals","volume":"122","author":"Kortylewski","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0310","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.oooo.2017.10.007_bib0315","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1158\/1535-7163.MCT-12-0923","article-title":"REST negatively and ISGF3 positively regulate the human STAT1 gene in melanoma","volume":"12","author":"Amalraj","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.oooo.2017.10.007_bib0320","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.3390\/ijms16024343","article-title":"Metastatic melanoma cells evade immune detection by silencing STAT1","volume":"16","author":"Osborn","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oooo.2017.10.007_bib0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10585-010-9310-7","article-title":"Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth","volume":"27","author":"Schultz","year":"2010","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.oooo.2017.10.007_bib0330","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1111\/j.1600-0625.2010.01072.x","article-title":"Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma","volume":"19","author":"Meyer","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0335","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1038\/jid.2008.26","article-title":"STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapy","volume":"128","author":"Wang","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.oooo.2017.10.007_bib0340","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1054\/bjom.2001.0713","article-title":"Amelanotic malignant melanomas of the oral mucosa","volume":"40","author":"Notani","year":"2002","journal-title":"Br J Oral Maxillofac Surg"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221244031731146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221244031731146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T05:00:04Z","timestamp":1535259604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221244031731146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S221244031731146X"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2017.10.007","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A preliminary immunohistochemical study of signal transducer and activator of transcription (STAT) proteins in primary oral malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}